213 related articles for article (PubMed ID: 20300048)
1. Common genetic variation of beta1- and beta2-adrenergic receptor and response to four classes of antihypertensive treatment.
Suonsyrjä T; Donner K; Hannila-Handelberg T; Fodstad H; Kontula K; Hiltunen TP
Pharmacogenet Genomics; 2010 May; 20(5):342-5. PubMed ID: 20300048
[TBL] [Abstract][Full Text] [Related]
2. Association of common polymorphisms in β1-adrenergic receptor with antihypertensive response to carvedilol.
Si D; Wang J; Xu Y; Chen X; Zhang M; Zhou H
J Cardiovasc Pharmacol; 2014 Oct; 64(4):306-9. PubMed ID: 25291495
[TBL] [Abstract][Full Text] [Related]
3. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
[TBL] [Abstract][Full Text] [Related]
4. Beta2-adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension.
Iaccarino G; Izzo R; Trimarco V; Cipolletta E; Lanni F; Sorriento D; Iovino GL; Rozza F; De Luca N; Priante O; Di Renzo G; Trimarco B
Clin Pharmacol Ther; 2006 Dec; 80(6):633-45. PubMed ID: 17178264
[TBL] [Abstract][Full Text] [Related]
5. Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.
Sehrt D; Meineke I; Tzvetkov M; Gültepe S; Brockmöller J
Pharmacogenomics; 2011 Jun; 12(6):783-95. PubMed ID: 21599570
[TBL] [Abstract][Full Text] [Related]
6. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP2D6 and ADRB1 genes with hypotensive and antichronotropic action of betaxolol in patients with arterial hypertension.
Zateyshchikov DA; Minushkina LO; Brovkin AN; Savel'eva EG; Zateyshchikova AA; Manchaeva BB; Nikitin AG; Sidorenko BA; Nosikov VV
Fundam Clin Pharmacol; 2007 Aug; 21(4):437-43. PubMed ID: 17635183
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms of beta1 adrenergic receptor and their influence on the cardiovascular responses to metoprolol in a South Indian population.
Mahesh Kumar KN; Ramu P; Rajan S; Shewade DG; Balachander J; Adithan C
J Cardiovasc Pharmacol; 2008 Nov; 52(5):459-66. PubMed ID: 19033826
[TBL] [Abstract][Full Text] [Related]
9. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension.
Liu J; Liu ZQ; Yu BN; Xu FH; Mo W; Zhou G; Liu YZ; Li Q; Zhou HH
Clin Pharmacol Ther; 2006 Jul; 80(1):23-32. PubMed ID: 16815314
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of the human beta-adrenergic receptors.
Taylor MR
Pharmacogenomics J; 2007 Feb; 7(1):29-37. PubMed ID: 16636683
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular approaches to individualize antihypertensive drug therapy.
Hiltunen TP; Kontula K
Ann Med; 2012 Jun; 44 Suppl 1():S23-9. PubMed ID: 22713145
[TBL] [Abstract][Full Text] [Related]
12. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
13. Haplotypes of the adrenergic system predict the blood pressure response to beta-blockers in women with essential hypertension.
Filigheddu F; Argiolas G; Degortes S; Zaninello R; Frau F; Pitzoi S; Bulla E; Bulla P; Troffa C; Glorioso N
Pharmacogenomics; 2010 Mar; 11(3):319-25. PubMed ID: 20235788
[TBL] [Abstract][Full Text] [Related]
14. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
15. Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years.
Masuo K; Katsuya T; Fu Y; Rakugi H; Ogihara T; Tuck ML
Circulation; 2005 Jun; 111(25):3429-34. PubMed ID: 15956122
[TBL] [Abstract][Full Text] [Related]
16. Job strain, job demands and adrenergic beta1-receptor-polymorphism: a possible interaction affecting blood pressure in men.
Ohlin B; Berglund G; Nilsson PM; Melander O
J Hypertens; 2008 Aug; 26(8):1583-9. PubMed ID: 18622236
[TBL] [Abstract][Full Text] [Related]
17. Association of beta 1-adrenergic receptor gene polymorphisms with left ventricular hypertrophy in human essential hypertension.
Fu C; Wang H; Wang S; Shi Y; Zhou X; Sun K; Chen J; Song X; Xue H; Hui R
Clin Biochem; 2008 Jul; 41(10-11):773-8. PubMed ID: 18298953
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics of antihypertensive treatment.
Arnett DK; Claas SA; Glasser SP
Vascul Pharmacol; 2006 Feb; 44(2):107-18. PubMed ID: 16356784
[TBL] [Abstract][Full Text] [Related]
19. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.
Iwai C; Akita H; Kanazawa K; Shiga N; Terashima M; Matsuda Y; Takai E; Miyamoto Y; Shimizu M; Kajiya T; Hayashi T; Yokoyama M
Am Heart J; 2003 Jul; 146(1):106-9. PubMed ID: 12851615
[TBL] [Abstract][Full Text] [Related]
20. Studies of associations between the Arg389Gly polymorphism of the beta1-adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects.
Gjesing AP; Andersen G; Albrechtsen A; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
Diabet Med; 2007 Apr; 24(4):392-7. PubMed ID: 17335470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]